Drug Trial Radar · NCT02328469
Aseptic Meningoencephalitis in Slovenia
Last checked: Nov 19, 2026Latest source record: May 4, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
800
Planned (sponsor's estimate)
Start
Jun 2014
Primary completion
Jun 2020
Study completion Jun 2020
Sponsor
- Lead sponsor
- University Medical Centre LjubljanaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Slovenian Research Agency; University of Ljubljana School of Medicine, Slovenia; Harvard University
- First posted
- Dec 31, 2014
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The main objective of this study is: * to establish etiology of acute aseptic meningitis/meningoencephalitis in Slovenia * to assess the clinical course and outcome of tick-borne encephalitis and Lyme neuroborreliosis * to characterize the inflammatory proteins, gene polymorphisms, and transcriptome profiles in patients with tick-borne encephalitis and Lyme neuroborreliosis
Conditions
- Aseptic Meningitis
Interventions
symptomatic therapyDrug
patients will receive symptomatic therapy with antipyretics, analgetics, antiemetics and parenteral hydration: metamizole, paracetamol, thiethylperazine, saline
Ceftriaxone or DoxycyclineDrug
beside symptomatic therapy (metamizole, paracetamol, thiethylperazine, saline), patients with proven or probable Lyme neuroborreliosis will be treated with ceftriaxone 2 g intravenously once daily for 14 days OR doxycycline 100 mg orally twice daily for 14 days
questionnaireOther
Control subjects will be asked to answer a questionnaire asking about the presence and frequency of nonspecific symptoms.
AcyclovirDrug
Patients will be treated with intravenous acyclovir 10 mg per kg three times daily for 14 to 21 days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Changes in selected clinical parameters in patients with acute aseptic meningitis/meningoencephalitisTime frame: at enrollment and during 12 months follow-up
- Changes in selected laboratory parameters in patients with acute aseptic meningitis/meningoencephalitisTime frame: at enrollment and during 12 months follow-up
- Changes in selected microbiologic parameters in patients with acute aseptic meningitis/meningoencephalitisTime frame: at enrollment and during 12 months follow-up
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Department of Infectious Diseases, University Medical Center Ljubljana, Ljubljana, Slovenia
Ljubljana, Slovenia · Recruiting
UMC Ljubljana, Department of Infectious Diseases
Ljubljana, Slovenia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.